Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Uriza G, Alwers R, Guerra OE., Onatra W. Guías de práctica clínica basadas en la evidencia: Menopausia. Proyecto ISS. Asociación Colombiana de Facultades de Medicina (ASCOFAME). [Fecha de acceso 4 de noviembre de 2007]. Disponible en la página web: http://www.ascofame.org.co/inicio/index.php?option
[2.]
M.T. Lopez.
El papel de las plantas medicinales en el tratamiento de la menopausia.
Offarm, 22 (2003 Nov), pp. 112-116
[3.]
Síntomas vasomotores de la menopausia.
Infac, 13 (2005), pp. 29-32
[4.]
B. Vanaclocha, S. Cañigueral.
editores. Fitoterapia.
Vademécum de prescripción, 4a,
[5.]
R.K. Klasco.
AltMedDex(R) System.
Thomson MICROMEDEX, Greenwood Village, Colorado, Vol 134 expires (12/2007),
[6.]
S.N. Chen, W. Li, D.S. Fabricant, B.D. Santarsiero, A. Mesecar, J.F. Fitzloff, et al.
Isolation, estructure elucidation, and absolute configuration of 26-deoxyactein from Cimicifuga racemosa and clarification of nomenclature associated with 27-deoxyactein.
J Nat Prod, 65 (2002 Apr), pp. 601-605
[7.]
P. Del Río, F. Lucena, M.J. Alonso, N. Casamitjana, E. Granda.
Fitoguía. Terapia con Plantas Medicinales,
[8.]
M.R. Rosas.
Soja. Nueva Terapéutica de tradición asiática.
Offarm, 25 (2006), pp. 80-86
[9.]
Informe del Comité Científico de la Agencia Española de Seguridad Alimentaria y Nutrición (Aesan) en relación con las consecuencias asociadas al consumo de isoflavonas.
Aesan, (2007-2002),
[10.]
Medline Plus. http://www.nlm.nih.gov/medlineplus/spanish/druginfo/ natural/patient-redclover.html [Fecha de acceso 23/03/2007]
[11.]
Utilización de fitoestrógenos en el tratamiento de los síntomas asociados a la menopausia.
Boletín Terapéutico Andaluz, 20 (2004), pp. 9-12
[12.]
Interpretando la literatura médica: ¿Qué necesito saber?.
Parte II. INFAC, 14 (2006), pp. 33-36
[13.]
Herbal Companion to AHFS DI,
[14.]
J. Barnes, L.A. Anderson, D. Phillipson.
Herbal medicines, 2a, Pharmaceutical Press;, (2002),
[15.]
E.M. Duker, L. Kopanski, H. Jarry, W. Wuttke.
Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats.
Planta Med, 57 (1991 Oct), pp. 420-424
[16.]
K. Raus, C. Brucker, C. Gorkow, W. Wuttke.
First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055.
Menopause, 13 (2006 Jul-Aug), pp. 678-691
[17.]
R.E. Nappi, B. Malavasi, B. Brundu, F. Facchinetti.
Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol.
Gynecol Endocrinol, 20 (2005 Jan), pp. 30-35
[18.]
J. Barnes.
Women's health.
Pharmaceutical journal, 270 (2003 Jan), pp. 16-18
[19.]
V. Viereck, C. Grundker, S.C. Friess, K.H. Frosch, D. Raddatz, M. Schoppet, et al.
Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
J Bone Miner Res, 20 (2005 Nov), pp. 2036-2043
[20.]
J. Barnes.
Herbal medicinal products for treating gynaecological complaints in women.
Pharmaceutical journal, 275 (2005 Oct), pp. 515-516
[21.]
W. Wuttke, D. Seldiova-Wuttke, C. Gorkow.
The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.
Maturitas, 44 (2003 Mar 14), pp. S67-S77
[22.]
L. Paulus.
Probiotics, saw palmetto, kampo and cannabis discussed in latest FACT: Herbal extracts and the menopause.
Pharmaceutical journal, 277 (2006), pp. 347
[23.]
R. Uebelhack, J.U. Blohmer, H.J. Graubaum, R. Busch, J. Gruenwald, K.D. Wernecke.
Black cohosh and St. John's wort for climacteric complaints: a randomized trial.
Obstet Gynecol, 107 (2006 Feb), pp. 247-255
[24.]
K.K. Han, J.M. Soares, M.A. Haidar, G. Rodrigues de Lima, E.C. Baracat.
Benefits of soy isoflavone therapeutic regimen on menopausal symptoms.
Obstetrics and gynecology, 99 (2002), pp. 389-394
[25.]
M. Bryant, A. Cassidy, C. Hill, J. Powell, D. Talbot, L. Dye.
Effect of consumption of isoflavones on behavioural, somatic and affective symptoms in women with premenstrual syndrome.
British Journal of Nutrition, 93 (2005), pp. 731-739
[26.]
J.C. Gallagher, R. Satpathy, K. Rafferty, V. Haynatzka.
The effect of soy protein isolate on bone metabolism.
Menopause, 11 (2004), pp. 290-298
[27.]
S. Kreijkamp-Kaspers, L. Kok, D.E. Grobbee, E.H.F. De Haan, A. Aleman, J.W. Lampe, Y.T. Van der Schouw.
Effect of soy protein containing isoflavones on cognitive function, bone mineral density and plasma lipids in postmenopausal women.
Jama, 292 (2004), pp. 65-74
[28.]
A. Crisafulli, D. Altavilla, G. Squadrito, A. Romeo, E.B. Adamo, R. Marini, et al.
Effects of phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor KB ligand-osteoprotegerin system in early postmenopausal women. J.
Clin Endocrinol Metab, 98 (2004), pp. 188-192
[29.]
Y.M. Chen, S.C. Ho, S.S. Lam, S.S.S. Ho, J.L.F. Woo.
Soy isoflavones have a favourable effect on bone loss in Chinese post-menopausal women with lower bone mass: a double-blind, randomised, controlled trial. J. clin. Endocrinol.
Metab, 88 (2003), pp. 4740-4747
[30.]
Consejo General de Colegios Oficiales de Farmacéuticos.
Plantas medicinales y fitoterapia III, (2003),
[31.]
A.M. Villar.
Soja. Aplicaciones múltiples.
Farmacia Profesional, 16 (2002), pp. 78-82
[32.]
E. Beltrán.
Isoflavonas y riesgo cardiovascular en la menopausia.
Ginecología y Obstetricia Clínica, 6 (2005), pp. 221-229
[33.]
M.C. Navarro.
Mecanismo de acción de las isoflavonas.
Ginecología y Obstetricia Clínica, 6 (2005), pp. 159-165
[34.]
W.L. Hall, K. Vafeiadon, J. Hallund, S. Bugel, M. Reimann, C. Koebnick, et al.
Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production.
Am J Clin Nutr, 83 (2006 Mar), pp. 592-600
[35.]
J. Hallund, S. Bugel, T. Tholstrup, M. Ferrari, D. Talbot, W.L. Hall, et al.
Soya isoflavone-enriched cereal bars affect markers of endothelial function in postmenopausal women.
N Br J Nutr, 95 (2006 Jun), pp. 1120-1126
[36.]
A. Garrido, M.P. De la Maza, S. Hirsch, L. Valladares.
Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal woman.
Maturitas, 54 (2006 Jun 20), pp. 270-276
[37.]
Consejo General de Colegios Oficiales de Farmacéuticos. Catálogo de Parafarmacia.
Colección consejo plus,
[38.]
M.L. Casini, G. Marelli, E. Papaleo, A. Ferrari, F. D'Ambrosio, V. Unfer.
Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized double-blind, crossover, placebo-controlled study.
Fertil Steril, 85 (2006 Apr), pp. 972-978
[39.]
J. Manonai, S. Songchitsomboon, K. Chanda, J.H. Hong, S. Komindr.
The effect of a soy-rich diet on urogenital atrophy: a randomized, cross-over trial.
Maturitas, 54 (2006 may 20), pp. 135-140
[40.]
N.L. Booth, C.E. Piersen, S. Banuvar, S.E. Geller, L.P. Shulman, N.R. Franswoth.
Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review.
Menopause, 13 (2006 mar-apr), pp. 251-261
[41.]
J. McKee, S.L. Warber.
Integrative therapies for menopause.
South Med J, 98 (2005 Mar), pp. 319-326
[42.]
P.H. Van de Weijer, R. Barentsen.
Isoflavones from red clover (Promensil®) significantly reduced menopausal hot flush symptoms compared with placebo.
Maturitas, 42 (2002 Jul), pp. 187-193
[43.]
C. Atkinson, J.E. Compston, N.E. Day, M. Dowsett, S.A. Bingham.
The effects of phytoestrogen isoflavones on bone density in women: a double- blind, randomized, controlled trial.
The American Journal of clinical nutrition, 79 (2004 Feb), pp. 326-333
[44.]
A. Sala, J. Vallés.
Plantas medicinales con actividad contra la osteoporosis.
El farmacéutico, 242 (2000), pp. 63-68
[45.]
L.A. Hidalgo, P.A. Chedrauni, N. Morocho, S. Ross, G. San Miguel.
The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, doubleblind, placebo-controlled study.
Gynecol Endocrinol, 21 (2005 Nov), pp. 257-264
[46.]
S.E. Geller, L. Studee.
Soy and red clover for mid-life and aging.
Climateric, 9 (2006 August), pp. 4
[47.]
T.M. Schult, K.E. Ensrud, T. Blackwell, B. Ettinger, R. Wallace, J.A. Tice.
Effect of isoflavones on lipids and bone turnover markers in menopausal women.
Maturitas, 48 (2004 Jul 15), pp. 209-218
[48.]
M.J. Campbell, J.V. Woodside, J.W. Honour, M.S. Morton, A.J. Leathem.
Effect of red clover-derived isoflavone supplementation on insulin- like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study.
European Journal of Clinical nutrition, 58 (2004 Jan), pp. 173-179
[49.]
J.B. Howes, D. Tran, D. Brillante, L.G. Howes.
Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes.
Diabetes, obesity & metabolism, 5 (2003 Sep), pp. 325-332
[50.]
J.B. Howes, K. Bray, L. Lorenz, P. Smederly, L.G. Howes.
The effects of dietary supplementation with isoflavones from red clover on cognitive function in postmenopausical women.
Climacteric: the journal of the international Menopause society, 7 (2004 Mar), pp. 70-77
[51.]
M. Imhof, A. Gocan, F. Reithmaryr, M. Lipovac, C. Schimitzek, P. Chedraui, J. Huber.
Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women.
Maturitas, 55 (2006 Aug), pp. 76-81
[52.]
W. Wuttke, H. Jarry, T. Becker, A. Schultens, V. Christoffel, C. Gorkow, D. Seidlova-Wuttke.
Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy?.
Maturitas, 143 (2003 Mar), pp. S9-S20
[53.]
L.P. Wolff, M.R. Martins, A.J. Bedone, I.M. Monteiro.
Endometrial evaluation in menopausal women after six months of isoflavones.
Rev Assoc Med Bras, 52 (2006 Nov-Dec), pp. 419-423
[54.]
Klasco Rk (Ed):reprotox. Thomson MICROMEDEX, Greenwood Village, Colorado (Vol 134 [expires 12/2007])
[55.]
G.E. Hale, C.L. Hughes, S.J. Robboy, S.K. Agarwal, M. Bievre.
A doubleblind randomized study on the effects of red clover isoflavone on the endometrium.
Menopause, 8 (2001 Sep-Oct), pp. 338-346
[56.]
I. Stockley.
Stockley's drug interactions, 6th Ed,
[57.]
P.J. Magee, I.R. Rowland.
Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer.
Br J. Nutr, 91 (2004 Apr), pp. 513-531
[58.]
S. Palacios, B. Pornel, C. Bergeron, P. Chantre, F. Nogalkes, L. Aubert, et al.
Endometrial safety assessment of a specific and standardized soy extract according to international guidelines.
Menopause, 14 (2007), pp. 1-6
[59.]
C. Atkinson, R.M. Warren, E. Sala, M. Dowsett, A.M. Dunning, C.S. Healey, et al.
Red clover derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial.
Breast cancer research: BCR, 6 (2004), pp. R170-R179
Copyright © 2009. Academia de Ciencias Médicas de Bilbao